Kamran Alam Taysha Gene Therapies, Inc. (TSHA) insider trading activity

Kamran Alam is CHIEF FINANCIAL OFFICER of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 1.55 Million shares of TSHA, which is worth approximately $6.51 Million. The most recent transaction as insider was on Jan 12, 2026, when has been sold 359,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.55M

30.23% 3M change

21.59% 12M change

Total Value Held $6.51 Million

Kamran Alam Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 12 2026	BUY Grant, award, or other acquisition	-	359,000 Added 18.84%	1,546,603 Common Stock
Aug 21 2025	SELL Open market or private sale	$155,299 $2.85 p/Share	54,491 Reduced 4.39%	1,187,603 Common Stock
Mar 11 2025	SELL Payment of exercise price or tax liability	$50,434 $1.69 p/Share	29,843 Reduced 2.35%	1,242,094 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	431,000 Added 25.31%	1,271,937 Common Stock
Feb 02 2024	SELL Payment of exercise price or tax liability	$1,944 $1.51 p/Share	1,288 Reduced 0.15%	840,937 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	590,413 Added 41.21%	842,225 Common Stock
Aug 24 2023	SELL Open market or private sale	$76,890 $2.33 p/Share	33,000 Reduced 11.34%	258,042 Common Stock

May 31 2023	BUY Grant, award, or other acquisition	-	6,230 Added 2.1%	291,042 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	18,691 Added 6.16%	284,812 Common Stock
Aug 23 2022	SELL Open market or private sale	$11,538 $3.47 p/Share	3,325 Reduced 1.23%	266,121 Common Stock
Aug 22 2022	SELL Open market or private sale	$34,010 $3.5 p/Share	9,717 Reduced 3.48%	269,446 Common Stock
Aug 19 2022	SELL Open market or private sale	$43,058 $3.75 p/Share	11,482 Reduced 3.95%	279,163 Common Stock
Aug 18 2022	SELL Open market or private sale	$28,932 $3.87 p/Share	7,476 Reduced 2.51%	290,645 Common Stock
Aug 20 2021	SELL Open market or private sale	$200,333 $16.92 p/Share	11,840 Reduced 3.82%	298,121 Common Stock
Aug 19 2021	SELL Open market or private sale	$167,147 $16.77 p/Share	9,967 Reduced 3.12%	309,961 Common Stock
Aug 18 2021	SELL Open market or private sale	$194,199 $17.35 p/Share	11,193 Reduced 3.38%	319,928 Common Stock

Kamran Alam

CHIEF FINANCIAL OFFICER

Dallas, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Value

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Taysha Gene Therapies, Inc.

Track Activities on TSHA

Account